• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgA 肾病牛津分类法的验证。

Validation of the Oxford classification of IgA nephropathy.

机构信息

Division of Nephrology, Toronto General Hospital, University of Toronto, Ontario, Canada.

出版信息

Kidney Int. 2011 Aug;80(3):310-7. doi: 10.1038/ki.2011.126. Epub 2011 May 4.

DOI:10.1038/ki.2011.126
PMID:21544062
Abstract

The Oxford classification of IgA nephropathy (IgAN) identified four pathological elements that were of prognostic value and additive to known clinical and laboratory variables in predicting patient outcome. These features are segmental glomerulosclerosis/adhesion, mesangial hypercellularity, endocapillary proliferation, and tubular atrophy/interstitial fibrosis. Here, we tested the Oxford results using an independent cohort of 187 adults and children with IgAN from 4 centers in North America by comparing the performance of the logistic regression model and the predictive value of each of the four lesions in both data sets. The cohorts had similar clinical and histological findings, presentations, and clinicopathological correlations. During follow-up, however, the North American cohort received more immunosuppressive and antihypertensive therapies. Identifying patients with a rapid decline in the rate of renal function using the logistic model from the original study in the validation data set was good (c-statistic 0.75), although less precise than in the original study (0.82). Individually, each pathological variable offered the same predictive value in both cohorts except mesangial hypercellularity, which was a weaker predictor. Thus, this North American cohort validated the Oxford IgAN classification and supports its utilization. Further studies are needed to determine the relationship to the impact of treatment and to define the value of the mesangial hypercellularity score.

摘要

牛津 IgA 肾病(IgAN)分类法确定了四个具有预后价值的病理特征,这些特征与已知的临床和实验室变量相加,可预测患者的预后。这些特征是节段性肾小球硬化/粘连、系膜细胞增生、毛细血管内增生和肾小管萎缩/间质纤维化。在这里,我们通过比较逻辑回归模型的性能以及在两个数据集的每个病变的预测值,使用来自北美 4 个中心的 187 名成人和儿童 IgAN 的独立队列对牛津结果进行了测试。这些队列具有相似的临床和组织学表现、表现和临床病理相关性。然而,在随访期间,北美队列接受了更多的免疫抑制和降压治疗。在验证数据集中,使用原始研究中的逻辑模型识别肾功能快速下降的患者的效果良好(C 统计量为 0.75),尽管不如原始研究准确(0.82)。在两个队列中,每个病理变量的预测价值都相同,除了系膜细胞增生,它是一个较弱的预测因素。因此,这个北美的队列验证了牛津 IgAN 分类,并支持其应用。需要进一步的研究来确定与治疗效果的关系,并定义系膜细胞增生评分的价值。

相似文献

1
Validation of the Oxford classification of IgA nephropathy.IgA 肾病牛津分类法的验证。
Kidney Int. 2011 Aug;80(3):310-7. doi: 10.1038/ki.2011.126. Epub 2011 May 4.
2
Oxford classification of immunoglobulin A nephropathy: an update.牛津系膜增生性肾小球肾炎分类法:更新。
Curr Opin Nephrol Hypertens. 2013 May;22(3):281-6. doi: 10.1097/MNH.0b013e32835fe65c.
3
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.牛津 IgA 肾病分类 2016 年更新:IgA 肾病分类工作组的报告。
Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22.
4
Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).儿童 IgA 肾病临床和组织病理学变量(牛津分类)预后的预测因素。
Nephrol Dial Transplant. 2012 Feb;27(2):715-22. doi: 10.1093/ndt/gfr339. Epub 2011 Jul 12.
5
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.牛津IgA肾病分类在不同临床表现和治疗的队列中的验证。
Kidney Int. 2014 Oct;86(4):828-36. doi: 10.1038/ki.2014.63. Epub 2014 Apr 2.
6
Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.无免疫抑制的IgA肾病患者毛细血管内细胞增多的预后价值
J Nephrol. 2016 Jun;29(3):367-375. doi: 10.1007/s40620-015-0227-8. Epub 2015 Aug 30.
7
The use of the Oxford classification of IgA nephropathy to predict renal survival.应用牛津 IgA 肾病分类法预测肾脏存活率。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2384-8. doi: 10.2215/CJN.01170211. Epub 2011 Sep 1.
8
The MEST score provides earlier risk prediction in lgA nephropathy.MEST 评分可更早预测 IgA 肾病的风险。
Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.
9
The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.牛津分类法在儿童 IgA 肾病中的应用与肾脏结局的相关性分析——一项回顾性队列研究。
BMC Nephrol. 2020 Jul 1;21(1):247. doi: 10.1186/s12882-020-01913-7.
10
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.IgA肾病的牛津分类:基本原理、临床病理相关性及分类
Kidney Int. 2009 Sep;76(5):534-45. doi: 10.1038/ki.2009.243. Epub 2009 Jul 1.

引用本文的文献

1
Development and validation of personalized risk prediction models for patients with IgA nephropathy: a nationwide multicenter cohort study.IgA肾病患者个性化风险预测模型的开发与验证:一项全国多中心队列研究
J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02338-x.
2
Association between different proportions of crescents and adverse renal outcomes in immunoglobulin a nephropathy: a systematic review and meta-analysis.免疫球蛋白A肾病中不同比例新月体与不良肾脏结局的关联:一项系统评价和荟萃分析
Ren Fail. 2025 Dec;47(1):2495104. doi: 10.1080/0886022X.2025.2495104. Epub 2025 May 21.
3
Kidney Outcomes with Corticosteroid Treatment in IgA Nephropathy According to the Oxford-MEST-C Classification.
根据牛津-MEST-C分类法,IgA肾病患者接受皮质类固醇治疗的肾脏预后
Glomerular Dis. 2025 Mar 20;5(1):191-199. doi: 10.1159/000545382. eCollection 2025 Jan-Dec.
4
Prognostic Utility of the MEST-C Score Combined With Clinical Parameters in Hispanic Patients With IgA Nephropathy.MEST-C评分联合临床参数对西班牙裔IgA肾病患者的预后评估价值
Int J Nephrol. 2025 Mar 5;2025:6974280. doi: 10.1155/ijne/6974280. eCollection 2025.
5
The Outcomes of IgA Nephropathy With Nephrotic Syndrome: A Clinicopathological Study From Northern India.IgA肾病合并肾病综合征的预后:来自印度北部的一项临床病理研究
Cureus. 2024 Dec 24;16(12):e76307. doi: 10.7759/cureus.76307. eCollection 2024 Dec.
6
Delta corticomedullary apparent diffusion coefficient on MRI as a biomarker for prognosis in IgA nephropathy.MRI上的皮质髓质Delta表观扩散系数作为IgA肾病预后的生物标志物
Ren Fail. 2025 Dec;47(1):2441394. doi: 10.1080/0886022X.2024.2441394. Epub 2024 Dec 17.
7
Association between different proportions of crescents and the progression of IgA nephropathy (IgAN): a systematic review and meta-analysis.新月体比例与 IgA 肾病(IgAN)进展的关系:系统评价和荟萃分析。
BMC Nephrol. 2024 Nov 5;25(1):396. doi: 10.1186/s12882-024-03839-w.
8
Significance of intrarenal vascular lesions in Ig A nephropathy prognosis.IgA 肾病预后中肾内血管病变的意义。
BMC Nephrol. 2024 Oct 16;25(1):355. doi: 10.1186/s12882-024-03803-8.
9
Histopathological correlations of CT-based radiomics imaging biomarkers in native kidney biopsy.基于 CT 的放射组学成像生物标志物在原发性肾脏活检中的组织病理学相关性。
BMC Med Imaging. 2024 Sep 27;24(1):256. doi: 10.1186/s12880-024-01434-x.
10
Monocytes and Macrophages in Kidney Disease and Homeostasis.肾脏疾病与稳态中的单核细胞和巨噬细胞
Int J Mol Sci. 2024 Mar 28;25(7):3763. doi: 10.3390/ijms25073763.